Literature DB >> 21196089

Oral administration of levo-tetrahydropalmatine attenuates reinstatement of extinguished cocaine seeking by cocaine, stress or drug-associated cues in rats.

Yazmin Figueroa-Guzman1, Christopher Mueller, Oliver Vranjkovic, Samantha Wisniewski, Zheng Yang, Shi-Jiang Li, Colin Bohr, Evan N Graf, David A Baker, John R Mantsch.   

Abstract

Cocaine addiction is characterized by a persistently heightened susceptibility to drug relapse. For this reason, the identification of medications that prevent drug relapse is a critical goal of drug abuse research. Drug re-exposure, the onset of stressful life events, and exposure to cues previously associated with drug use have been identified as determinants of relapse in humans and have been found to reinstate extinguished cocaine seeking in rats. This study examined the effects of acute oral (gavage) administration of levo-tetrahydropalmatine (l-THP), a tetrahydroprotoberberine isoquinoline with a pharmacological profile that includes antagonism of D1, D2 and D3 dopamine receptors, on the reinstatement of extinguished cocaine seeking by a cocaine challenge (10mg/kg, ip), a stressor (uncontrollable electric footshock [EFS]) or response-contingent exposure to a stimulus (tone and light complex) previously associated with drug delivery in male Sprague-Dawley rats. Extinguished drug seeking was reinstated by ip cocaine, EFS, or response-contingent presentation of drug-associated cues in vehicle-pretreated rats following extinction of iv cocaine self-adminisration. Oral administration of either 3.0 or 10.0mg/kg l-THP 1h prior to reinstatement testing significantly attenuated reinstatement by each of the stimuli. Food-reinforced responding and baseline post-extinction responding were significantly attenuated at the 10.0, but not the 3.0mg/kg, l-THP dose, indicating that the effects of 3mg/kg l-THP on reinstatement were likely independent of non-specific motor impairment. These findings further suggest that l-THP may have utility for the treatment of cocaine addiction.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196089      PMCID: PMC3466100          DOI: 10.1016/j.drugalcdep.2010.11.023

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  78 in total

1.  Systemic administration of a dopamine, but not a serotonin or norepinephrine, transporter inhibitor reinstates cocaine seeking in the rat.

Authors:  Heath D Schmidt; R Christopher Pierce
Journal:  Behav Brain Res       Date:  2006-09-15       Impact factor: 3.332

2.  The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Zheng-Xiong Xi; Amy Hauck Newman; Jeremy G Gilbert; Arlene C Pak; Xiao-Qing Peng; Charles R Ashby; Leah Gitajn; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2005-10-05       Impact factor: 7.853

3.  l-tetrahydropalmatine increases leucine enkephalin levels in corpus striatum of rats.

Authors:  X Z Zhu; Z Zhou; X Q Ji; J Gu; L G Luo; F S Wang
Journal:  Zhongguo Yao Li Xue Bao       Date:  1991-03

4.  Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors.

Authors:  L Cervo; F Carnovali; J A Stark; T Mennini
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

5.  Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf striatum.

Authors:  X Guo; L M Wang; J Liu; G Z Jin
Journal:  Zhongguo Yao Li Xue Bao       Date:  1997-05

6.  Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.

Authors:  H D Schmidt; R C Pierce
Journal:  Neuroscience       Date:  2006-07-14       Impact factor: 3.590

Review 7.  Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

Authors:  M L Wadenberg
Journal:  Neurosci Biobehav Rev       Date:  1996       Impact factor: 8.989

8.  Drug-induced plasticity contributing to heightened relapse susceptibility: neurochemical changes and augmented reinstatement in high-intake rats.

Authors:  Aric Madayag; Kristen S Kau; Doug Lobner; John R Mantsch; Samantha Wisniewski; David A Baker
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

9.  Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A.

Authors:  Patricia Di Ciano; Rachel J Underwood; Jim J Hagan; Barry J Everitt
Journal:  Neuropsychopharmacology       Date:  2002-06-18       Impact factor: 7.853

10.  Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.

Authors:  John R Mantsch; Shi-Jiang Li; Robert Risinger; Sarah Awad; Eric Katz; David A Baker; Zheng Yang
Journal:  Psychopharmacology (Berl)       Date:  2007-03-15       Impact factor: 4.415

View more
  19 in total

Review 1.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

Review 2.  l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Authors:  Jia Bei Wang; John R Mantsch
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

Review 4.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

Review 5.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

6.  Simultaneous determination of L-tetrahydropalmatine and cocaine in human plasma by simple UPLC-FLD method: application in clinical studies.

Authors:  Mingming Yu; Hazem E Hassan; Ahmed Ibrahim; Kenneth S Bauer; Deanna L Kelly; Jia Bei Wang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-06-20       Impact factor: 3.205

7.  Levo-tetrahydropalmatine decreases ethanol drinking and antagonizes dopamine D2 receptor-mediated signaling in the mouse dorsal striatum.

Authors:  Taehyun Kim; David J Hinton; Sandy Johng; Jia Bei Wang; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2013-01-31       Impact factor: 3.332

8.  Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Hazem E Hassan; Deanna Kelly; Moshe Honick; Sagar Shukla; Ahmed Ibrahim; David A Gorelick; Matthew Glassman; Robert P McMahon; Heidi J Wehring; Ann Marie Kearns; Stephanie Feldman; Mingming Yu; Ken Bauer; Jia Bei Wang
Journal:  J Clin Pharmacol       Date:  2016-08-04       Impact factor: 3.126

9.  Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.

Authors:  Sudharshan Madapa; Satishkumar Gadhiya; Thomas Kurtzman; Ian L Alberts; Steven Ramsey; Maarten Reith; Wayne W Harding
Journal:  Eur J Med Chem       Date:  2016-09-14       Impact factor: 6.514

10.  L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.

Authors:  Wei Xu; Yujun Wang; Zhongze Ma; Yi-Ting Chiu; Peng Huang; Khampaseuth Rasakham; Ellen Unterwald; David Y-W Lee; Lee-Yuan Liu-Chen
Journal:  Drug Alcohol Depend       Date:  2013-09-02       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.